{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18236", "batch_size": 200, "batch_pos": 22, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "Factual reporting of numbers; lacks high-potency language.", "method": "llm_batch", "batch_id": "batch_2_16408", "batch_size": 200, "batch_pos": 196, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The segment uses 'secures' and 'includes' which are not moderate verbs from the approved list.", "method": "llm_batch", "batch_id": "batch_3_21256", "batch_size": 200, "batch_pos": 158, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_20736", "batch_size": 200, "batch_pos": 155, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports facts about a deal ('secures up to', 'includes an option') without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_16604", "batch_size": 200, "batch_pos": 151, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_14144", "batch_size": 200, "batch_pos": 114, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment reports details and contains no bare negation.", "method": "llm_batch", "batch_id": "batch_7_14596", "batch_size": 200, "batch_pos": 101, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "no", "rationale": "The segment describes deal details, not capability or preparedness.", "method": "llm_batch", "batch_id": "batch_8_21464", "batch_size": 200, "batch_pos": 176, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 9, "answer": "no", "rationale": "The segment reports a deal secures doses and option for more, not economic metric changes.", "method": "llm_batch", "batch_id": "batch_9_20648", "batch_size": 200, "batch_pos": 124, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 10, "answer": "no", "rationale": "The segment describes a current deal and future option, which relates to preparedness, not speculation about future relief from the outbreak.", "method": "llm_batch", "batch_id": "batch_10_17012", "batch_size": 200, "batch_pos": 168, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 11, "answer": "no", "rationale": "No direct quote from a named or institutional speaker.", "method": "llm_batch", "batch_id": "batch_11_13636", "batch_size": 200, "batch_pos": 166, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 12, "answer": "yes", "rationale": "No explicit framing cues remain; facts presented purely factually.", "method": "llm_batch", "batch_id": "batch_12_5364", "batch_size": 200, "batch_pos": 166, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
